- PR Newswire•2 days ago
MARIETTA, Ga., April 24, 2017 /PRNewswire/ -- MiMedx Group, Inc. (MDXG), the leading biopharmaceutical company developing and marketing regenerative biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, announced today Company's participation in the European Wound Management Association ("EWMA") 2017 Conference to be held in Amsterdam, The Netherlands from May 3 through May 5, 2017. The 2017 EWMA Conference is EWMA's 27th annual conference offering high-level scientific presentations, knowledge and best practices exchange, and presentation of the most recent advances in wound management research and treatment.
- Benzinga•5 days ago
A number of stocks are looking strong technically this week with the market's upside reversal. Here are four to watch. Akorn, Inc. (NASDAQ: AKRX ) had a strong reversal session on Tuesday, up $1.05 or ...
- MarketWatch•6 days ago
Harry Boxer sums up what the charts are telling him about these four stocks.
MDXG : Summary for MiMedx Group, Inc - Yahoo Finance
MiMedx Group, Inc. (MDXG)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||8.15 x 100|
|Ask||30.00 x 100|
|Day's Range||11.45 - 11.80|
|52 Week Range||6.64 - 12.16|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||104.82|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|